By Professor Bruce Neal

Journal articles

Li C; Yu J; Hockham C; Perkovic V; Neuen BL; Badve SV; Houston L; Lee VYJ; Barraclough JY; Fletcher RA; Mahaffey KW; Heerspink HJL; Cannon CP; Neal B; Arnott C, 2022, 'Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis', Diabetes, Obesity and Metabolism, 24, pp. 1927 - 1938, http://dx.doi.org/10.1111/dom.14772

Yin X; Rodgers A; Perkovic A; Huang L; Li KC; Yu J; Wu Y; Wu JHY; Marklund M; Huffman MD; Miranda JJ; Di Tanna GL; Labarthe D; Elliott P; Tian M; Neal B, 2022, 'Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis', Heart, 108, pp. 1608 - 1615, http://dx.doi.org/10.1136/heartjnl-2022-321332

Marklund M; Tullu F; Thout SR; Yu J; Brady TM; Appel LJ; Neal B; Wu JHY; Gupta R, 2022, 'Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study', Hypertension, 79, pp. 2188 - 2198, http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.19072

Sen T; Koshino A; Neal B; Bijlsma MJ; Arnott C; Li J; Hansen MK; Ix JH; Heerspink HJL, 2022, 'Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial', Diabetes, Obesity and Metabolism, 24, pp. 1950 - 1956, http://dx.doi.org/10.1111/dom.14779

Maganja D; Trieu K; Reading M; Huang L; Hart AC; Taylor F; Stamatellis S; Arnott C; Feng X; Schutte AE; Di Tanna GL; Ni Mhurchu C; Cameron AJ; Huffman MD; Neal B; Wu JH, 2022, 'Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial', American Heart Journal, 252, pp. 70 - 83, http://dx.doi.org/10.1016/j.ahj.2022.06.007

Arnott C; Fletcher RA; Neal B, 2022, 'Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk', Heart Failure Clinics, 18, pp. 645 - 654, http://dx.doi.org/10.1016/j.hfc.2022.03.008

Nadkarni GN; Takale D; Neal B; Mahaffey KW; Yavin Y; Hansen MK; Fleming F; Heerspink HJL; Coca SG, 2022, 'A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease', Kidney360, 3, pp. 1599 - 1602, http://dx.doi.org/10.34067/KID.0002172022

Liu Y; Xiao S; Yin X; Gao P; Wu J; Xiong S; Hockham C; Hone T; Wu JHY; Pearson SA; Neal B; Tian M, 2022, 'Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review', Public Health Reviews, 43, pp. 1605025, http://dx.doi.org/10.3389/phrs.2022.1605025

Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K; Agodoa L; Algra A; Asselbergs FW; Beckett N; Berge E; Black H; Brouwers FPJ; Brown M; Bulpitt CJ; Byington B; Cutler J; Devereaux RB; Dwyer J; Estacio R; Fagard R; Fox K; Fukui T; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis J; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer C; Patel A; Pfeffer M; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Pitt B; Rodgers A; Rothwell P; Salimi-Khorshidi G; Sundström J, 2022, 'Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis', The Lancet Diabetes and Endocrinology, 10, pp. 645 - 654, http://dx.doi.org/10.1016/S2213-8587(22)00172-3

Crosby S; Rajadurai E; Jan S; Neal B; Holden R, 2022, 'The effects on clinical trial activity of direct funding and taxation policy interventions made by government: A systematic review', PLoS ONE, 17, pp. e0269021, http://dx.doi.org/10.1371/journal.pone.0269021

Bablani L; Ni Mhurchu C; Neal B; Skeels CL; Staub KE; Blakely T, 2022, 'Effect of voluntary Health Star Rating labels on healthier food purchasing in New Zealand: Longitudinal evidence using representative household purchase data', BMJ Nutrition, Prevention and Health, 5, pp. 227 - 234, http://dx.doi.org/10.1136/bmjnph-2022-000459

Li JW; Arnott C; Heerspink HJL; Mbiostat QL; Cannon CP; Wheeler DC; Charytan DM; Barraclough J; Figtree GA; Agarwal R; Bakris G; de Zeeuw D; Greene T; Levin A; Pollock C; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Neal B; Jardine MJ, 2022, 'Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial', Journal of the American Heart Association, 11, pp. e025045, http://dx.doi.org/10.1161/JAHA.121.025045

Ferrannini E; Baldi S; Scozzaro T; Tsimihodimos V; Tesfaye F; Shaw W; Rosenthal N; Figtree GA; Neal B; Mahaffey KW; Perkovic V; Hansen MK, 2022, 'Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)', Diabetes Care, 45, pp. 1893 - 1899, http://dx.doi.org/10.2337/dc21-2398

Juraschek SP; Wang D; McEvoy JW; Harrap S; Harris K; Mancia G; Marre M; Neal B; Patel A; Poulter NR; Williams B; Chalmers J; Woodward M; Selvin E, 2022, 'Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE', International Journal of Cardiology, 358, pp. 103 - 109, http://dx.doi.org/10.1016/j.ijcard.2022.04.044

Liao J; Kang A; Xia C; Young T; Di Tanna GL; Arnott C; Pollock C; Krishnan AV; Agarwal R; Bakris G; Charytan DM; de Zeeuw D; Heerspink HJL; Levin A; Neal B; Wheeler DC; Zhang H; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ; Smyth B, 2022, 'The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial', Diabetes and Metabolism, 48, pp. 101331, http://dx.doi.org/10.1016/j.diabet.2022.101331

Barraclough JY; Yu J; Figtree GA; Perkovic V; Heerspink HJL; Neuen BL; Cannon CP; Mahaffey KW; Schutte AE; Neal B; Arnott C, 2022, 'Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial', Diabetes, Obesity and Metabolism, 24, pp. 1072 - 1083, http://dx.doi.org/10.1111/dom.14671

Li KC; Huang L; Tian M; Di Tanna GL; Yu J; Zhang X; Yin X; Liu Y; Hao Z; Zhou B; Feng X; Li Z; Zhang J; Sun J; Zhang Y; Zhao Y; Zhang R; Yu Y; Li N; Yan LL; Labarthe DR; Elliott P; Wu Y; Neal B; Lung T; Si L, 2022, 'Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study', Circulation, 145, pp. 1534 - 1541, http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059573

Neuen BL; Oshima M; Agarwal R; Arnott C; Cherney DZ; Edwards R; Langkilde AM; Mahaffey KW; McGuire DK; Neal B; Perkovic V; Pong A; Sabatine MS; Raz I; Toyama T; Wanner C; Wheeler DC; Wiviott SD; Zinman B; Heerspink HJL, 2022, 'Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized, Controlled Trials', Circulation, 145, pp. 1460 - 1470, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057736

Schutte AE; Neal B, 2022, 'The sodium hidden in medication: a tough pill to swallow', European Heart Journal, 43, pp. 1756 - 1758, http://dx.doi.org/10.1093/eurheartj/ehab888

Bhat S; Coyle DH; Trieu K; Neal B; Mozaffarian D; Marklund M; Wu JHY, 2022, 'Reply to A Coskun and B Oz', Advances in Nutrition, 13, pp. 692 - 693, http://dx.doi.org/10.1093/advances/nmac005

Vaduganathan M; Sattar N; Xu J; Butler J; Mahaffey KW; Neal B; Shaw W; Rosenthal N; Pfeifer M; Hansen MK; Januzzi JL, 2022, 'Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin', Journal of the American College of Cardiology, 79, pp. 432 - 444, http://dx.doi.org/10.1016/j.jacc.2021.11.027

Waijer SW; Sen T; Arnott C; Neal B; Kosterink JGW; Mahaffey KW; Parikh CR; de Zeeuw D; Perkovic V; Neuen BL; Coca SG; Hansen MK; Gansevoort RT; Heerspink HJL, 2022, 'Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease', Clinical Journal of the American Society of Nephrology, 17, pp. 251 - 259, http://dx.doi.org/10.2215/CJN.08780621

Heerspink HJL; Oshima M; Zhang H; Li J; Agarwal R; Capuano G; Charytan DM; Craig J; de Zeeuw D; Di Tanna GL; Levin A; Neal B; Perkovic V; Wheeler DC; Yavin Y; Jardine MJ, 2022, 'Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial', American Journal of Kidney Diseases, 79, pp. 244 - 256.e1, http://dx.doi.org/10.1053/j.ajkd.2021.05.005

Coyle DH; Shahid M; Dunford EK; Ni Mhurchu C; Scapin T; Trieu K; Marklund M; Chun Yu Louie J; Neal B; Wu JHY, 2022, 'The Contribution of Major Food Categories and Companies to Household Purchases of Added Sugar in Australia', Journal of the Academy of Nutrition and Dietetics, 122, pp. 345 - 353.e3, http://dx.doi.org/10.1016/j.jand.2021.06.013

Campbell NRC; Whelton PK; Orias M; Wainford RD; Cappuccio FP; Ide N; Neal B; Cohn J; Cobb LK; Webster J; Trieu K; He FJ; McLean RM; Blanco-Metzler A; Woodward M; Khan N; Kokubo Y; Nederveen L; Arcand JA; MacGregor GA; Owolabi MO; Lisheng L; Parati G; Lackland DT; Charchar FJ; Williams B; Tomaszewski M; Romero CA; Champagne B; L’Abbe MR; Weber MA; Schlaich MP; Fogo A; Feigin VL; Akinyemi R; Inserra F; Menon B; Simas M; Neves MF; Hristova K; Pullen C; Pandeya S; Ge J; Jalil JE; Wang JG; Wideimsky J; Kreutz R; Wenzel U; Stowasser M; Arango M; Protogerou A; Gkaliagkousi E; Fuchs FD; Patil M; Chan AWK; Nemcsik J; Tsuyuki RT; Narasingan SN; Sarrafzadegan N; Ramos ME; Yeo N; Rakugi H; Ramirez AJ; Álvarez G; Berbari A; Kim CI; Ihm SH; Chia YC; Unurjargal T; Park HK; Wahab K; McGuire H; Dashdorj NJ; Ishaq M; Ona DID; Mercado-Asis LB; Prejbisz A; Leenaerts M; Simão C; Pinto F; Almustafa BA; Spaak J; Farsky S; Lovic D; Zhang XH, 2022, '2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action', Journal of Human Hypertension, 37, http://dx.doi.org/10.1038/s41371-022-00690-0

Canoy D; Copland E; Nazarzadeh M; Ramakrishnan R; Pinho-Gomes AC; Salam A; Dwyer JP; Farzadfar F; Sundström J; Woodward M; Davis BR; Rahimi K; Neal B; Abdul Salam M, 2022, 'Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials', Heart, 108, pp. 1281 - 1289, http://dx.doi.org/10.1136/heartjnl-2021-320171

Lam D; Nadkarni GN; Mosoyan G; Neal B; Mahaffey KW; Rosenthal N; Hansen MK; Heerspink HJL; Fleming F; Coca SG, 2022, 'Clinical utility of KidneyIntelX in early stages of diabetic kidney disease in the CANVAS trial', American Journal of Nephrology, 53, pp. 21 - 31, http://dx.doi.org/10.1159/000519920

Li JW; Guo YT; Di Tanna GL; Neal B; Chen YD; Schutte AE, 2022, 'Erratum: Vital Signs During the COVID-19 Outbreak: A Retrospective Analysis of 19,960 Participants in Wuhan and Four Nearby Capital Cities in China (Global Heart (2021) 16: 1 (47) DOI: 10.5334/gh.913)', Global Heart, 17, pp. 88, http://dx.doi.org/10.5334/GH.1172

Bowman L; Weidinger F; Albert MA; Fry ETA; Pinto FJ; Achenbach S; Casadei B; Collins R; Devereaux PJ; Douglas PS; Frobert O; Goto S; Grines C; Harrington RA; Haynes R; Hochman JS; James S; Kirchhof P; Komajda M; Lam CSP; Landray M; Maggioni A; McMurray J; Medhurst N; Mehran R; Neal B; Rydén L; Thiele H; Van Gelder I; Wallentin L; Yusuf S; Zannad F, 2022, 'Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation', Global Heart, 17, pp. 85, http://dx.doi.org/10.5334/GH.1178

Fletcher RA; Arnott C; Rockenschaub P; Schutte AE; Carpenter L; Vaduganathan M; Heerspink HJ; Neal B; Jun M; Rodgers A; Perkovic V; Neuen B, 2022, 'Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials', Hypertension, 79, http://dx.doi.org/10.1161/hyp.79.suppl_1.p201

Wu JH; Trieu K; Coyle D; Huang L; Wijesuriya N; Nallaiah K; Lung T; Di Tanna GL; Zheng M; Mozaffarian D; MacMillan F; Simmons D; Wu T; Twigg S; Gauld A; Constantino M; McGill M; Wong J; Neal B, 2022, 'Testing the Feasibility and Dietary Impact of a "Produce Prescription" Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia.', J Nutr, 152, pp. 2409 - 2418, http://dx.doi.org/10.1093/jn/nxac152

Neal B; Tian M; Wu Y, 2021, 'Salt Substitute and Cardiovascular Events and Death. Reply', The New England journal of medicine, 385, pp. 2493 - 2494, http://dx.doi.org/10.1056/nejmc2116824

Neuen BL; Oshima M; Perkovic V; Agarwal R; Arnott C; Bakris G; Cannon CP; Charytan DM; Edwards R; Górriz JL; Jardine MJ; Levin A; Neal B; De Nicola L; Pollock C; Rosenthal N; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial', European Heart Journal, 42, pp. 4891 - 4901, http://dx.doi.org/10.1093/eurheartj/ehab497

Liu Y; Chu H; Peng K; Yin X; Huang L; Wu Y; Pearson SA; Li N; Elliott P; Yan LL; Labarthe DR; Hao Z; Feng X; Zhang J; Zhang Y; Zhang R; Zhou B; Li Z; Sun J; Zhao Y; Yu Y; Tian M; Neal B; Liu H, 2021, 'Factors Associated with the Use of a Salt Substitute in Rural China', JAMA Network Open, 4, pp. e2137745, http://dx.doi.org/10.1001/jamanetworkopen.2021.37745

Sen T; Li J; Neuen BL; Arnott C; Neal B; Perkovic V; Mahaffey KW; Shaw W; Canovatchel W; Hansen MK; Heerspink HJL, 2021, 'Association between circulating gdf-15 and cardio-renal outcomes and effect of canagliflozin: Results from the canvas trial', Journal of the American Heart Association, 10, pp. e021661, http://dx.doi.org/10.1161/JAHA.121.021661

Trevena H; Neal B; Downs SM; Davis T; Sacks G; Crino M; Thow AM, 2021, 'Drawing on Strategic Management Approaches to Inform Nutrition Policy Design: An Applied Policy Analysis for Salt Reduction in Packaged Foods', International journal of health policy and management, 10, pp. 896 - 908, http://dx.doi.org/10.34172/ijhpm.2020.204

Coyle DH; Shahid M; Dunford EK; Louie JCY; Trieu K; Marklund M; Neal B; Wu JHY, 2021, 'Estimating the potential impact of the Australian government’s reformulation targets on household sugar purchases', International Journal of Behavioral Nutrition and Physical Activity, 18, pp. 138, http://dx.doi.org/10.1186/s12966-021-01208-6

Liu Y; Li N; Yan N; Pan XF; Li Q; Micha R; Mozaffarian D; Huffman MD; Wang Y; Neal B; Tian M; Zhao Y; Wu JHY, 2021, 'Protocol for a randomized controlled trial to test the acceptability and adherence to 6-months of walnut supplementation in Chinese adults at high risk of cardiovascular disease', Nutrition Journal, 20, pp. 3, http://dx.doi.org/10.1186/s12937-020-00660-7

Golledge J; Arnott C; Moxon J; Monaghan H; Norman R; Morris D; Li Q; Jones G; Roake J; Bown M; Neal B, 2021, 'Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm', Trials, 22, pp. 962, http://dx.doi.org/10.1186/s13063-021-05915-0

Feng KY; Li JW; Ianus J; de Zeeuw D; Fulcher GR; Pfeifer M; Matthews DR; Jardine MJ; Perkovic V; Neal B; Mahaffey KW, 2021, 'Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis', Diabetes, Obesity and Metabolism, 23, pp. 2707 - 2715, http://dx.doi.org/10.1111/dom.14525

Dana LM; Chapman K; Dixon H; Miller C; Neal B; Kelly B; Ball K; Pettigrew S, 2021, 'The relative importance of primary food choice factors among different consumer groups: A latent profile analysis', Food Quality and Preference, 94, pp. 104199, http://dx.doi.org/10.1016/j.foodqual.2021.104199

Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M, 2021, 'Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program', Diabetologia, 64, pp. 2402 - 2414, http://dx.doi.org/10.1007/s00125-021-05524-1

Brown LJ; Meredith T; Yu J; Patel A; Neal B; Arnott C; Lim E; Yu J, 2021, 'Heart failure therapies for the prevention of her2-monoclonal antibody-mediated cardiotoxicity: A systematic review and meta-analysis of randomized trials', Cancers, 13, pp. 5527, http://dx.doi.org/10.3390/cancers13215527

Huang L; Neal B; Wu JHY; Huang Y; Marklund M; Campbell NRC; He FJ; Yoshimura S; Chalmers J; Trieu K, 2021, 'The impact of baseline potassium intake on the dose–response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials', Journal of Human Hypertension, 35, pp. 946 - 957, http://dx.doi.org/10.1038/s41371-021-00510-x

Ndanuko RN; Shahid M; Jones A; Harris T; Maboreke J; Walker A; Raubenheimer D; Simpson SJ; Neal B; Wu JHY; Peters SAE; Woodward M, 2021, 'Projected effects on salt purchases following implementation of a national salt reduction policy in South Africa', Public Health Nutrition, 24, pp. 4614 - 4621, http://dx.doi.org/10.1017/S1368980020005273

Neuen BL; Oshima M; Perkovic V; Arnott C; Bakris G; Cannon CP; Charytan DM; Jardine M; Levin A; Neal B; Pollock C; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial', European Heart Journal, 42, pp. ehab724.2647, http://dx.doi.org/10.1093/eurheartj/ehab724.2647

Sen T; Li J; Neuen BL; Neal B; Arnott C; Parikh CR; Coca SG; Perkovic V; Mahaffey KW; Yavin Y; Rosenthal N; Hansen MK; Heerspink HJL, 2021, 'Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial', Diabetologia, 64, pp. 2147 - 2158, http://dx.doi.org/10.1007/s00125-021-05512-5

Trieu K; Coyle DH; Afshin A; Neal B; Marklund M; Wu JHY, 2021, 'The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study', PLoS Medicine, 18, pp. e1003806, http://dx.doi.org/10.1371/journal.pmed.1003806

Barraclough JY; Patel S; Yu J; Neal B; Arnott C, 2021, 'The role of sodium glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease: A narrative review of potential mechanisms', Cells, 10, pp. 2699, http://dx.doi.org/10.3390/cells10102699

Rahimi K; Bidel Z; Nazarzadeh M; Copland E; Canoy D; Wamil M; Majert J; McManus R; Adler A; Agodoa L; Algra A; Asselbergs FW; Beckett NS; Berge E; Black H; Boersma E; Brouwers FPJ; Brown M; Brugts JJ; Bulpitt CJ; Byington RP; Cushman WC; Cutler J; Devereaux RB; Dwyer JP; Estacio R; Fagard R; Fox K; Fukui T; Gupta AK; Holman RR; Imai Y; Ishii M; Julius S; Kanno Y; Kjeldsen SE; Kostis J; Kuramoto K; Lanke J; Lewis E; Lewis JB; Lievre M; Lindholm LH; Lueders S; MacMahon S; Mancia G; Matsuzaki M; Mehlum MH; Nissen S; Ogawa H; Ogihara T; Ohkubo T; Palmer CR; Patel A; Pfeffer MA; Pitt B; Poulter NR; Rakugi H; Reboldi G; Reid C; Remuzzi G; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen JA; Suzuki H; Thijs L; Ueshima K; Umemoto S; van Gilst WH; Verdecchia P; Wachtell K; Whelton P; Wing L; Woodward M; Yui Y; Yusuf S; Zanchetti A; Zhang ZY; Anderson C; Baigent C; Brenner BM; Collins R; de Zeeuw D; Lubsen J; Malacco E; Neal B; Perkovic V; Rodgers A; Rothwell P; Salimi-Khorshidi G; Sundström J; Turnbull F; Viberti G; Wang J; Chalmers J; Davis BR, 2021, 'Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis', The Lancet, 398, pp. 1053 - 1064, http://dx.doi.org/10.1016/S0140-6736(21)01921-8

Back to profile page